デフォルト表紙
市場調査レポート
商品コード
1241742

In Vitro(体外)診断の世界市場

In Vitro Diagnostics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
In Vitro(体外)診断の世界市場
出版日: 2023年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

In Vitro(体外)診断の世界市場は2030年に1,343億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に1,030億米ドルと推定されるIn Vitro(体外)診断の世界市場は、2030年までに1,343億米ドルの改定規模に達し、2022年から2030年にかけてCAGR 3.4%で成長すると予測されます。本レポートで分析したセグメントの一つである試薬・キットは、CAGR3.2%を記録し、分析期間終了時には863億米ドルに達すると予測されます。パンデミック後の回復を考慮し、機器分野の成長は、今後8年間のCAGRが3.9%に修正されました。

米国市場は276億米ドル、中国はCAGR5.1%で成長すると予測

米国のIn Vitro(体外)診断市場は、2022年に276億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが5.1%となり、2030年には271億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ2.2%と2.7%の成長が予測されています。欧州では、ドイツがCAGR2.6%で成長すると予測されています。

調査対象企業の例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Johnson & Johnson
  • Ortho Clinical Diagnostics
  • Qiagen NV
  • Roche Diagnostics(Schweiz)AG
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
目次
Product Code: MCP12549

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global In Vitro Diagnostics Market to Reach $134.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for In Vitro Diagnostics estimated at US$103 Billion in the year 2022, is projected to reach a revised size of US$134.3 Billion by 2030, growing at aCAGR of 3.4% over the period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record 3.2% CAGR and reach US$86.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 3.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $27.6 Billion, While China is Forecast to Grow at 5.1% CAGR

The In Vitro Diagnostics market in the U.S. is estimated at US$27.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$27.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 2.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 58 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Johnson & Johnson
  • Ortho Clinical Diagnostics
  • Qiagen NV
  • Roche Diagnostics (Schweiz) AG
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • In Vitro Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World In Vitro Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for In Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Data Management Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Data Management Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Data Management Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Immunoassay / Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Immunoassay / Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Immunoassay / Immunochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Coagulation & Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Urinalysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Urinalysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: World 16-Year Perspective for Urinalysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: World 16-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Point-Of-Care Testing Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Point-Of-Care Testing Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: World 16-Year Perspective for Point-Of-Care Testing Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: World 16-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 59: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: USA 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: USA 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: USA 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • JAPAN
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 77: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • CHINA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: China Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: China 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: China Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: China 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: China Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: China 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • EUROPE
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 95: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for In Vitro Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • FRANCE
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: France Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: France 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: France Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: France 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: France Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: France 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • GERMANY
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: UK 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: UK 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: UK 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Spain 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 152: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Russia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Russia 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 155: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Russia 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Rest of Europe 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for In Vitro Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 182: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Australia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Australia 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 185: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Australia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Australia 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 188: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Australia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Australia 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • INDIA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 191: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: India Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: India 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 194: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: India Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: India 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 197: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: India Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: India 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 200: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: South Korea Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: South Korea 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 203: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: South Korea Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: South Korea 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 206: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: South Korea Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: South Korea 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 209: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Latin America Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Latin America 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 221: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Latin America Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Latin America 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 224: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 225: Latin America Historic Review for In Vitro Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Latin America 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 227: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Latin America Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Latin America 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 230: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Argentina Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Argentina 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 233: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Argentina Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Argentina 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 236: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Argentina Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Argentina 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 239: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Brazil Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Brazil 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 242: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Brazil Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Brazil 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 245: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Brazil Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Brazil 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 248: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Mexico Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Mexico 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 251: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Mexico Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Mexico 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 254: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Mexico Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Mexico 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 257: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Rest of Latin America Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 260: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Rest of Latin America Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Rest of Latin America Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Middle East Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Middle East 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 269: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Middle East Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Middle East 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 272: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 273: Middle East Historic Review for In Vitro Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: Middle East 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 275: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Middle East Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: Middle East 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 278: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Iran Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: Iran 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 281: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Iran Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: Iran 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 284: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Iran Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: Iran 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 287: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Israel Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: Israel 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 290: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Israel Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: Israel 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 293: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Israel Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: Israel 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 296: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Saudi Arabia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR